SL
Saglam, Leyla
24 papers · 121 citations · 2021–2026
Publications
24
Citations
121
Years
6
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Evaluation of ICAM and VCAM as biomarkers in serum and bronchoscopic lavage samples of lung cancer patients
|
2026 | Article | 0 |
|
Serum Ang 1, Ang 1-7, and Mas levels as potential biomarkers in obstructive sleep apnea syndrome
|
2025 | Article | 0 |
|
Can apelins guide the diagnosis of coronary artery disease in COPD patients?
|
2025 | Article | 1 |
|
The Importance of Multisystem Evaluation in Diagnosing Birt-Hogg-Dubé Syndrome: A Case Report
|
2024 | Letter | 0 |
|
COMPARISON OF METHOTREXATE AND METHYLPREDNISOLONE AS ADDITION TO ANTIFIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS DUE TO COVID-19
|
2024 | Article | 1 |
|
The effect of compliance with PAP therapy on biochemical parameters in patients with obstructive sleep apnea syndrome: A 6-month follow-up study
|
2024 | Article | 1 |
|
Evaluation of Pulmonary Function Tests, Dyspnea Scores, and Antibody Levels at the Six-Month Follow-Up of Patients Hospitalized for COVID-19 Pneumonia
|
2024 | Article | 1 |
|
Evaluation of Lipocalin-2 and-10 Levels at Time of Diagnosis in Patients with Acute Pulmonary Embolism
|
2023 | Article | 0 |
|
Analysis of one-year follow-up results and treatment costs of patients with PTE in a tertiary care center
|
2023 | Article | 0 |
|
Evaluation of the Relationship between FeNO and Clinical Risk Stratification for Early Mortality in Pulmonary Embolism
|
2023 | Article | 0 |
|
Evaluation of the Effect of COVID-19 Lung Involvement on Cardiorespiratory Fitness at 3 and 6 months
|
2023 | Letter | 0 |
|
Effect of atmospheric pressure changes on the development of pulmonary embolism a retrospective analysis of 8 years of data
|
2023 | Article | 2 |
|
Using clinical parameters to determine the optimal dose of thrombolytic treatment in acute pulmonary thromboembolism
|
2022 | Article | 0 |
|
Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism
|
2022 | Article | 1 |
|
Investigation of the need for computed tomography pulmonary angiography in the decision to discontinue treatment for pulmonary thromboembolism
|
2022 | Article | 0 |
|
Response to "An appraisal of high-flow nasal cannula oxygen therapy in hypoxic pulmonary embolism patients"
|
2022 | Letter | 0 |
|
Evaluation of the relationship between KIM-1 and suPAR level in COVID-19 patients and a different perspective on suPAR
|
2021 | Meeting Abstract | 0 |
|
Comparison of the effectiveness of high-flow and conventional nasal cannula oxygen therapy in pulmonary embolism patients with acute hypoxemic respiratory failure
|
2021 | Article | 4 |
|
Comparison of high-flow and conventional nasal cannula oxygen in patients undergoing endobronchial ultrasonography
|
2021 | Article | 23 |
|
Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19
|
2021 | Article | 12 |
|
Could VEGF-D level have a role in clinical risk scoring, estimation of thrombus burden, and treatment in acute pulmonary thromboembolism?
|
2021 | Article | 6 |
|
Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR
|
2021 | Article | 24 |
|
Can hematological parameters guide the differentiation between sarcoidosis and tuberculous lymphadenitis?
|
2021 | Article | 1 |
|
Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome
|
2021 | Article | 44 |